US govt has unveiled names of first 10 drugs whose prices will be subjected to negotiations between Medicare & manufacturers, amid massive pushback by the big pharma lobby.
Initial talks held on the possibility of India entering the programme that was started in 2017 between France, Germany and Spain to ensure European sovereignty in defence and security.
COMMENTS